The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1.
Gavin E MorrisMatthew J DenniffElisavet KaramanaviSarah A AndrewsRenata B KostogrysVasiliki BountzioukaMaryam Ghaderi-NajafabadiNoor ShamkhiGeorge McConnellMichael A KaiserLaura CarletonChristine SchofieldThorsten KesslerRichard D RainbowNilesh J SamaniThomas R WebbPublished in: British journal of pharmacology (2022)
Our studies reveal a novel role for SVEP1 and the integrins α4β1 and α9β1 in reducing VSMC contractility. This could provide an explanation for the genetic associations with blood pressure risk at the SVEP1 and ITGA9 loci.